Key points are not available for this paper at this time.
Carriers of different pathMMR variants exhibit distinct patterns of cancer risk and survival as they age. Risk estimates for counselling and planning of surveillance and treatment should be tailored to each patient's age, gender and pathMMR variant. We have updated our open-access website www. lscarisk. org to facilitate this.
Møller et al. (Fri,) studied this question.